Target intelligence / Profile preview

Novel protein, similar to CD24 molecule CD52

Molecular classification: Other

Overview

This entry represents a novel, uncharacterized protein in Homo sapiens, currently annotated as “novel protein, similar to CD24 molecule CD52.” Its name indicates sequence or predicted structural similarity to CD24 and CD52, both of which are established cell surface glycoproteins associated with immune cell function. However, no protein structure, tissue specificity, functional annotation, biological role, or therapeutic relevance has been validated for ENSG00000289710 at this time[5][1][9]. It is only listed in gene and protein databases as a "protein coding gene" with no known function.

Beyond the preview

Go deeper on Novel protein, similar to CD24 molecule CD52.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel protein, similar to CD24 molecule CD52.

Explore the full profile